A New Approach to Migraines from Amgen
Recombinetics is Improving Animal Welfare Using Biotechnology
Janssen Pharmaceuticals’ New Model Will Put Patients First
First Approved Treatment using RNAi – Alnylam Pharmaceuticals’ and BIO Chair John Maraganore
Curing the Worlds Most Debilitating Diseases -- Dr. Penny Heaton, Gates MRI CEO
Monday Highlights: BIO 2018
By Theresa Brady, January 11, 2019
Roy Zwahlen took a long shot when he requested a meeting with an investment firm ...
By Connor McKoy, November 29, 2018
Last June, BIO hosted its 2018 International Convention in Boston. The week-long conference featured countless discussions related to ...
By Kara Nelson, November 01, 2018
A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation ...
By Connor McKoy, July 19, 2018
Following Food, Health and Environmental Future Day at the 2018 BIO International Convention, BIO’s Executive ...